Endothelial activation and circulating markers of endothelial activation in kidney disease
- PMID: 20498676
- DOI: 10.1038/nrneph.2010.65
Endothelial activation and circulating markers of endothelial activation in kidney disease
Abstract
The recognition of a central role for the endothelium in the development of kidney disease or the development of vascular lesions in patients with established renal dysfunction has led to the emergence of methods to test different aspects of endothelium function, including in endothelium injury and repair. Endothelial-cell activation is associated with the shedding of components of the glycocalyx, adhesion molecules and endothelial microparticles into the circulation. This process may eventually result in the detachment of endothelial cells and recruitment of circulating myeloid and progenitor cells that are involved in vascular remodeling and repair. Circulating markers of endothelium activation may therefore represent novel markers of vessel wall injury. This Review describes the biology of these circulating markers of vessel wall injury, the methodologies used to measure them, and their possible relevance to patients with kidney disease.
Similar articles
-
Circulating endothelial cells: a new biomarker of endothelial dysfunction in hematological diseases.Ann Biol Clin (Paris). 2016 Aug 1;74(4):395-404. doi: 10.1684/abc.2016.1160. Ann Biol Clin (Paris). 2016. PMID: 27492692 Review. English.
-
Vascular endothelial cell activation in models of vascular and glomerular injury.Kidney Int Suppl. 1994 Feb;45:S37-44. Kidney Int Suppl. 1994. PMID: 8158895 Review.
-
Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding.Am J Pathol. 2020 Apr;190(4):768-780. doi: 10.1016/j.ajpath.2019.11.016. Epub 2020 Feb 6. Am J Pathol. 2020. PMID: 32035885 Review.
-
Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease.Int Angiol. 2024 Dec;43(6):563-590. doi: 10.23736/S0392-9590.24.05339-2. Int Angiol. 2024. PMID: 39873224 Review.
-
Circulating endothelial cells: markers of vascular dysfunction.Clin Lab. 2005;51(9-10):531-8. Clin Lab. 2005. PMID: 16285476 Review.
Cited by
-
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.Mediators Inflamm. 2015;2015:614357. doi: 10.1155/2015/614357. Epub 2015 Oct 11. Mediators Inflamm. 2015. PMID: 26538831 Free PMC article.
-
An evolving new paradigm: endothelial cells--conditional innate immune cells.J Hematol Oncol. 2013 Aug 22;6:61. doi: 10.1186/1756-8722-6-61. J Hematol Oncol. 2013. PMID: 23965413 Free PMC article. Review.
-
Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness.J Clin Hypertens (Greenwich). 2014 Apr;16(4):295-300. doi: 10.1111/jch.12287. Epub 2014 Mar 19. J Clin Hypertens (Greenwich). 2014. PMID: 24641802 Free PMC article.
-
Ginsenoside Rg1 attenuates high glucose-induced endothelial barrier dysfunction in human umbilical vein endothelial cells by protecting the endothelial glycocalyx.Exp Ther Med. 2019 May;17(5):3727-3733. doi: 10.3892/etm.2019.7378. Epub 2019 Mar 13. Exp Ther Med. 2019. PMID: 30988758 Free PMC article.
-
Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury.Kidney Int. 2018 Feb;93(2):365-374. doi: 10.1016/j.kint.2017.08.014. Epub 2017 Oct 20. Kidney Int. 2018. PMID: 29061334 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical